Amylyx Pharmaceuticals Growth Metrics (2022-2026) | AMLX

1Y3Y5Y7Y10YAll
Download Data
Growth Metrics Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y) (Quarter) -0.78M1.59M0.02M-0.01M-0.75M-1.82M0.64M
EBITDA Margin Growth (3y) (Quarter) -1.01M
EBITDA Margin (QoQ) (Quarter) 1.56M0.02M0.00M-234.00-0.00M-0.01M-0.73M-1.07M2.46M
EBIT Margin Growth (1y) (Quarter) -0.78M1.59M0.02M-0.01M-0.75M-1.82M0.64M
EBIT Margin Growth (3y) (Quarter) -1.01M
EBIT Margin (QoQ) (Quarter) 1.56M0.02M0.00M-234.00-0.00M-0.01M-0.73M-1.07M2.46M
EBT Margin Growth (1y) (Quarter) -0.75M1.56M0.02M-0.01M-0.71M-1.75M0.60M
EBT Margin Growth (3y) (Quarter) -0.94M
EBT Margin (QoQ) (Quarter) 1.54M0.02M0.00M-262.00-0.00M-0.01M-0.70M-1.04M2.35M
Enterprise Value Growth (1y) (Quarter) -260.96%-35.45%-72.86%-118.36%-7.04%-7.99%13.28%33.98%52.47%45.33%41.63%-46.76%-79.59%-37.10%
Enterprise Value Growth (3y) (Quarter) -22.46%7.18%4.36%-28.38%2.97%6.81%
Enterprise Value (QoQ) (Quarter) -165.51%19.01%21.33%-113.38%0.37%-3.36%0.62%-4.60%-0.52%17.01%24.34%24.70%-15.62%11.39%-90.23%7.85%11.74%
FCF Margin Growth (1y) (Quarter) -0.52M1.26M0.02M682.00-0.65M-1.00M0.93M
FCF Margin Growth (3y) (Quarter) -0.26M
FCF Margin (QoQ) (Quarter) 1.24M0.02M0.00M-0.00M0.00M-0.00M-0.65M-0.35M1.93M
Gross Margin Growth (1y) (Quarter) 0.00M426.0069.00490.00508.00863.00
Gross Margin (QoQ) (Quarter) 0.00M549.00171.0060.00-355.00192.00592.0078.000.00M
Interest Coverage Ratio Growth (1y) (Quarter) -10,490.08%98.68%136.52%205.44%104.34%-1,100,636.82%-87,666.53%-7,089.38%-107.96%93.06%98.84%97.67%-232.24%92.84%
Interest Coverage Ratio Growth (3y) (Quarter) 28.51%-115.99%-54.88%-19.81%77.45%-279.50%
Interest Coverage Ratio (QoQ) (Quarter) -73.85%31.88%52.05%-18,548.58%99.98%1,984.97%38.44%667.04%-5,599.18%-49.95%88.95%99.13%-4,694.27%74.88%77.80%-24.30%-3.31%
Net Margin Growth (1y) (Quarter) -0.75M1.56M0.02M-0.01M-0.71M-1.75M-0.40M
Net Margin Growth (3y) (Quarter) -0.94M
Net Margin (QoQ) (Quarter) 1.54M0.02M0.00M-213.00-0.00M-0.01M-0.70M-1.04M1.35M
Operating Margin Growth (1y) (Quarter) -0.78M1.59M0.02M-0.01M-0.75M-1.82M0.64M
Operating Margin Growth (3y) (Quarter) -1.01M
Operating Margin (QoQ) (Quarter) 1.56M0.02M0.00M-234.00-0.00M-0.01M-0.73M-1.07M2.46M
Return on Assets Growth (1y) (Quarter) 0.00M0.00M1.001.000.00M0.00M-1.00-1.00-1.000.00M1.001.000.00M
Return on Assets Growth (3y) (Quarter) 0.00M0.00M1.000.00M0.00M
Return on Assets (QoQ) (Quarter) 0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M0.00M
Return on Capital Employed Growth (1y) (Quarter) 0.00M0.00M0.01M0.01M0.00M-0.00M-0.01M-0.02M-0.01M-0.00M0.01M0.01M0.01M
Return on Capital Employed Growth (3y) (Quarter) -0.00M-0.00M0.00M0.00M-890.00
Return on Capital Employed (QoQ) (Quarter) 363.00-0.00M0.00M0.00M0.00M0.00M0.00M-0.00M-0.00M-0.01M-0.00M0.00M0.00M0.00M0.00M-643.00
Return on Sales Growth (1y) (Quarter) -75.00156.002.00-1.00-71.00-175.00-40.00-193.00637.00310.00
Return on Sales Growth (3y) (Quarter) -94.00291.00
Return on Sales (QoQ) (Quarter) 154.002.000.00M0.00M0.00M-1.00-70.00-104.00135.00-154.00760.00-431.00